| Autor: |
Freyberg Z; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Sonders MS; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA.; Department of Neurology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA., Aguilar JI; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Hiranita T; Psychobiology Section, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA., Karam CS; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Flores J; Department of Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA., Pizzo AB; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Zhang Y; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Farino ZJ; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA., Chen A; Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, Hatos Center for Neuropharmacology, David Geffen School of Medicine University of California, Los Angeles, California 90095, USA., Martin CA; UCLA Interdepartmental Program in Molecular Toxicology, University of California, Los Angeles, California 90095, USA., Kopajtic TA; Psychobiology Section, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA., Fei H; Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, Hatos Center for Neuropharmacology, David Geffen School of Medicine University of California, Los Angeles, California 90095, USA., Hu G; Department of Chemistry, Columbia University, New York, New York 10027, USA., Lin YY; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Republic of China 10055., Mosharov EV; Department of Neurology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA., McCabe BD; Center for Motor Neuron Biology and Disease, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Department of Pathology and Cell Biology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Department of Neuroscience, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA., Freyberg R; Department of Psychology, Stern College for Women, Yeshiva University, New York, New York 10016, USA., Wimalasena K; Department of Chemistry, Wichita State University, Wichita, Kansas 67260, USA., Hsin LW; School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Republic of China 10055., Sames D; Department of Chemistry, Columbia University, New York, New York 10027, USA., Krantz DE; Department of Psychiatry and Biobehavioral Sciences and Semel Institute for Neuroscience and Human Behavior, Hatos Center for Neuropharmacology, David Geffen School of Medicine University of California, Los Angeles, California 90095, USA., Katz JL; Psychobiology Section, Intramural Research Program, Department of Health and Human Services, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland 21224, USA., Sulzer D; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA.; Department of Neurology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Department of Pharmacology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA., Javitch JA; Department of Psychiatry, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, New York 10032, USA.; Department of Pharmacology, College of Physicians &Surgeons, Columbia University, New York, New York 10032, USA. |
